Glenmark initiates Phase 3 clinical trials on antiviral Favipiravir for COVID-19 patients in India EP News Bureau May 26, 2020 Glenmark is the first company in India to initiate Phase 3 clinical trials on Favipiravir for COVID-19 patients in India
